eiaab home > Protein center > HAVCR1(Gene name) > Human
  • Add your favorite
  • HAVCR1 (Gene name),
  • Hepatitis A virus cellular receptor 1 (Protein name ),  HAVR1_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Database Reference
  • |
  • Paper References
  • Gene name:
    HAVCR1(KIM1;TIM1;TIMD1);
    Protein name:
    Hepatitis A virus cellular receptor 1(HAVcr-1);
    Alternative:
    TIM-1(TIM);T-cell membrane protein 1;Kidney injury molecule 1(KIM-1);T-cell immunoglobulin and mucin domain-containing protein 1(TIMD-1);
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    N/A
    Function:
    May play a role in T-helper cell development and the regulation of asthma and allergic diseases. Receptor for TIMD4 (By similarity). In case of human hepatitis A virus (HHAV) infection, functions as a cell-surface receptor for the virus. May play a role in kidney injury and repair.
    Subcellular Location:
    Membrane Single-pass type I membrane protein
    Protein Attributes:
    Sequence length:
    359
    Sequence:
    50:
    MHPQVVILSL | ILHLADSVAG | SVKVGGEAGP | SVTLPCHYSG | AVTSMCWNRG | 
    100:
    SCSLFTCQNG | IVWTNGTHVT | YRKDTRYKLL | GDLSRRDVSL | TIENTAVSDS | 
    150:
    GVYCCRVEHR | GWFNDMKITV | SLEIVPPKVT | TTPIVTTVPT | VTTVRTSTTV | 
    200:
    PTTTTVPTTT | VPTTMSIPTT | TTVLTTMTVS | TTTSVPTTTS | IPTTTSVPVT | 
    250:
    TTVSTFVPPM | PLPRQNHEPV | ATSPSSPQPA | ETHPTTLQGA | IRREPTSSPL | 
    300:
    YSYTTDGNDT | VTESSDGLWN | NNQTQLFLEH | SLLTANTTKG | IYAGVCISVL | 
    350:
    VLLALLGVII | AKKYFFKKEV | QQLSVSFSSL | QIKALQNAVE | KEVQAEDNIY | 
    359:
    IENSLYATD
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Database Reference
    Pfam:
    MIM:
    UniGene:
    SMR:
    KEGG:
    String:
    Uniprot:
     
    FOR
    ELISA Kit for Human HAVcr-1
    Cat.:
    E0785m
    Price:
    $496.0
    MSDS:
    Packing:
    96T
    Range:
    0.156-10 ng/mL
    ELISA Kit for Human HAVcr-1
    Cat.:
    E0785h
    Price:
    $476.0
    MSDS:
    Packing:
    96T
    Range:
    0.156-10 ng/mL
    ELISA Kit for Human HAVcr-1
    Cat.:
    E0785r
    Price:
    $496.0
    MSDS:
    Packing:
    96T
    Range:
    0.156-10 ng/mL
    CLIA Kit for Human HAVcr-1
    Cat.:
    U0785h
    Price:
    $736.0
    MSDS:
    Packing:
    96T
    Range:
    19.5-1250 pg/mL
    CLIA Kit for Human HAVcr-1
    Cat.:
    U0785m
    Price:
    $776.0
    MSDS:
    Packing:
    96T
    Range:
    19.5-1250 pg/mL
    CLIA Kit for Human HAVcr-1
    Cat.:
    U0785r
    Price:
    $796.0
    MSDS:
    Packing:
    96T
    Range:
    19.5-1250 pg/mL
    Polyclonal Antibody for Human HAVcr-1
    Cat.:
    P0785Rb-h
    Price:
    $398.0
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human HAVcr-1
    Cat.:
    P0785Rb-r
    Price:
    $398.0
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human HAVcr-1
    Cat.:
    P0785Rb-m
    Price:
    $398.0
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human HAVcr-1
    Monoclonal Antibody for Human HAVcr-1
    Monoclonal Antibody for Human HAVcr-1
    Protein for Human HAVcr-1
    Protein for Human HAVcr-1
    Protein for Human HAVcr-1

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision

    Intra-assay Precision (Precision within an assay):Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

    Intra-Assay CV: ≤3.6%

    Inter-assay Precision (Precision between assays):Three samples of known concentration were tested in five separate assays to assess inter-assay precision.

    Inter-Assay CV: ≤6.9%

    Intra-assay Precision (Precision within an assay):Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

    Intra-Assay CV: ≤4.3%

    Inter-assay Precision (Precision between assays):Three samples of known concentration were tested in five separate assays to assess inter-assay precision.

    Inter-Assay CV: ≤7.8%

    Intra-assay Precision (Precision within an assay):Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

    Intra-Assay CV: ≤4.5%

    Inter-assay Precision (Precision between assays):Three samples of known concentration were tested in five separate assays to assess inter-assay precision.

    Inter-Assay CV: ≤8.9%

    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery

    Recovery was determined by spiking various levels of HAVcr-1 into serum and plasma .

    Sample Type

    Average(%)

    Recovery  Range (%)

    Serum

    95

    92-98

    Plasma

    89

    86-93

    Recovery was determined by spiking various levels of HAVcr-1 into serum and plasma .

    Sample Type

    Average(%)

    Recovery  Range (%)

    Serum

    104

    94-110

    Plasma

    96

    89-105

     

     

     

     

    Recovery was determined by spiking various levels of HAVcr-1 into serum and plasma .

    Sample Type

    Average(%)

    Recovery  Range (%)

    Serum

    102

    95-114

    Plasma

    96

    93-99

    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity

    The linearity of the kit was assayed by testing samples spiked with appropriate concentration of HAVcr-1 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.  

    Sample

    1:2

    1:4

    1:8

    1:16

    serum(n=5)

    89-93%

    89-101%

    86-99%

    93-102%

    EDTA plasma(n=5)

    92-104%

    88-101%

    82-93%

    86-91%

    heparin plasma(n=5)

    86-98%

     

    84-95%

    83-92%

    90-103%

    The linearity of the kit was assayed by testing samples spiked with appropriate concentration of HAVcr-1 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.  

    Sample               

    1:2

    1:4

    1:8

    1:16

    serum(n=5)

    89-103%

    86-101%

    83-99%

    97-110%

    EDTA plasma(n=5)

    97-108%

    88-101%

    79-102%

    89-99%

    heparin plasma(n=5)

    86-98%

     

    86-99%

    94-108%

    90-103%

    The linearity of the kit was assayed by testing samples spiked with appropriate concentration of HAVcr-1 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.  

    Sample

    1:2

    1:4

    1:8

    1:16

    serum(n=5)

    89-101%

    90-105%

    93-97%

    93-107%

    EDTA plasma(n=5)

    95-110%

    89-97%

    94-110%

    88-99%

    heparin plasma(n=5)

    86-99%

     

    88-96%

    99-114%

    92-105%

    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Product References
    [2].
    Zaid Abassi, Amjad Shalabi, Rima Sohotnik, Omri Nativ, Hoda Awad, Bishara Bishara, Victor Frajewicki, Igor Sukhotnik, Abeer Abbasi, Ofer Nativ
    [3].
    Rima Sohotnik, Omri Nativ, Abeer Abbasi, Hoda Awad, Victor Frajewicki, Bishara Bishara, Igor Sukhotnik, Zaher Armaly, Doron Aronson, Samuel N. Heyman, Ofer Nativ, and Zaid Abassi
    Product Feedback Wall